Abrdn Life Sciences Investors (HQL) Competitors $13.50 +0.35 (+2.66%) (As of 12/20/2024 04:33 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends HQL vs. CET, MFIC, NMFC, BCSF, BBDC, CGBD, HQH, PHK, BTO, and ECCShould you be buying Abrdn Life Sciences Investors stock or one of its competitors? The main competitors of Abrdn Life Sciences Investors include Central Securities (CET), MidCap Financial Investment (MFIC), New Mountain Finance (NMFC), Bain Capital Specialty Finance (BCSF), Barings BDC (BBDC), Carlyle Secured Lending (CGBD), Abrdn Healthcare Investors (HQH), PIMCO High Income Fund (PHK), John Hancock Financial Opportunities Fund (BTO), and Eagle Point Credit (ECC). These companies are all part of the "financial services" industry. Abrdn Life Sciences Investors vs. Central Securities MidCap Financial Investment New Mountain Finance Bain Capital Specialty Finance Barings BDC Carlyle Secured Lending Abrdn Healthcare Investors PIMCO High Income Fund John Hancock Financial Opportunities Fund Eagle Point Credit Central Securities (NYSE:CET) and Abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, community ranking, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk. Do institutionals & insiders have more ownership in CET or HQL? 8.7% of Central Securities shares are owned by institutional investors. Comparatively, 32.2% of Abrdn Life Sciences Investors shares are owned by institutional investors. 10.3% of Central Securities shares are owned by insiders. Comparatively, 10.1% of Abrdn Life Sciences Investors shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is CET or HQL a better dividend stock? Central Securities pays an annual dividend of $2.25 per share and has a dividend yield of 4.9%. Abrdn Life Sciences Investors pays an annual dividend of $1.86 per share and has a dividend yield of 13.8%. Does the media prefer CET or HQL? In the previous week, Central Securities' average media sentiment score of 0.00 equaled Abrdn Life Sciences Investors'average media sentiment score. Company Overall Sentiment Central Securities Neutral Abrdn Life Sciences Investors Neutral Is CET or HQL more profitable? Company Net Margins Return on Equity Return on Assets Central SecuritiesN/A N/A N/A Abrdn Life Sciences Investors N/A N/A N/A Which has higher valuation & earnings, CET or HQL? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCentral Securities$300.48M4.30N/AN/AN/AAbrdn Life Sciences Investors$86.69M4.26N/AN/AN/A Which has more volatility and risk, CET or HQL? Central Securities has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Comparatively, Abrdn Life Sciences Investors has a beta of 0.71, meaning that its share price is 29% less volatile than the S&P 500. Does the MarketBeat Community believe in CET or HQL? Abrdn Life Sciences Investors received 95 more outperform votes than Central Securities when rated by MarketBeat users. CompanyUnderperformOutperformCentral SecuritiesN/AN/AAbrdn Life Sciences InvestorsOutperform Votes9568.35% Underperform Votes4431.65% SummaryCentral Securities beats Abrdn Life Sciences Investors on 4 of the 7 factors compared between the two stocks. Ad Paradigm Press Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!Click here now for the urgent details. Get Abrdn Life Sciences Investors News Delivered to You Automatically Sign up to receive the latest news and ratings for HQL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HQL vs. The Competition Export to ExcelMetricAbrdn Life Sciences InvestorsInvestment offices IndustryFinance SectorNYSE ExchangeMarket Cap$369.24M$8.38B$11.03B$19.18BDividend Yield13.94%6.75%9.79%3.60%P/E RatioN/A0.4428.1741.26Price / Sales4.2614.8247.4217.60Price / CashN/A7.0330.4221.28Price / BookN/A0.882.745.32Net IncomeN/A$73.96M$1.03B$989.88M7 Day Performance-2.46%-2.96%-2.88%-3.54%1 Month Performance-2.39%-2.31%-2.87%-3.68%1 Year Performance2.97%3.73%11.33%12.14% Abrdn Life Sciences Investors Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HQLAbrdn Life Sciences InvestorsN/A$13.50+2.7%N/A+4.0%$369.24M$86.69M0.00N/ACETCentral SecuritiesN/A$46.85+0.6%N/A+21.9%$1.33B$300.48M0.006MFICMidCap Financial Investment2.299 of 5 stars$13.49-1.6%$14.71+9.1%-1.2%$1.27B$121.29M8.79N/ANews CoveragePositive NewsNMFCNew Mountain Finance2.1696 of 5 stars$11.72-0.6%$11.00-6.1%-12.7%$1.26B$124.62M11.23N/AEx-DividendInsider TradeNews CoveragePositive NewsBCSFBain Capital Specialty Finance1.5079 of 5 stars$17.17-0.4%$17.00-1.0%+10.8%$1.11B$297.79M8.661,000BBDCBarings BDC2.2792 of 5 stars$9.60-1.1%$10.00+4.2%+8.0%$1.01B$289.20M8.9926Positive NewsCGBDCarlyle Secured Lending0.9603 of 5 stars$17.86+0.1%$16.67-6.7%+16.4%$909.25M$241.63M9.97N/APositive NewsHQHAbrdn Healthcare InvestorsN/A$16.92-0.3%N/A+1.4%$856.49MN/A0.00147,000News CoveragePositive NewsPHKPIMCO High Income FundN/A$5.01-0.4%N/A+0.5%$732.10M$92.95M0.00147,000BTOJohn Hancock Financial Opportunities FundN/A$36.66-0.7%N/A+16.9%$722.79M$132.65M0.002,719Positive NewsECCEagle Point Credit3.4393 of 5 stars$8.98-0.2%$10.00+11.4%-5.0%$691.01M$139.07M11.25N/ANews Coverage Related Companies and Tools Related Companies CET Competitors MFIC Competitors NMFC Competitors BCSF Competitors BBDC Competitors CGBD Competitors HQH Competitors PHK Competitors BTO Competitors ECC Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:HQL) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Share Abrdn Life Sciences Investors With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
